XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Schedule of share repurchase program

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands, except share and per share data)

2025

2024

2025

2024

Number of shares repurchased

2,143,099

Total share repurchased cost

$

$

$

26,772

$

Average total cost per repurchased share

$

$

$

12.49

$

Schedule of allocation of total stock-based compensation expense

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

(In thousands)

    

2025

    

2024

    

2025

    

2024

Cost of revenue

$

96

$

100

$

296

$

286

Sales and marketing expenses

379

595

1,347

1,939

Research and development expenses

45

42

130

123

Reimbursement, general and administrative expenses

1,294

1,333

4,046

3,621

Total stock-based compensation expense

$

1,814

$

2,070

$

5,819

$

5,969

Schedule of stock option activity

    

Weighted-

Weighted-

Average

Average

Aggregate

Options

Exercise Price

Remaining

Intrinsic

(In thousands except options and per share data)

Outstanding

Per Share

Contractual Life

Value (1)

Balance at December 31, 2024

394,871

$

40.70

2.8 years

$

309

Exercised

(2,364)

$

4.23

$

22

Cancelled/Expired

(139,966)

$

41.74

Balance at September 30, 2025

252,541

$

40.46

2.2 years

$

169

Options exercisable at September 30, 2025

244,660

$

41.51

2.18 years

$

123

(1)The aggregate intrinsic value of options exercised represents the difference between the exercise price of the option and the closing stock price of our common stock on the date of exercise. The aggregate intrinsic value of options outstanding represents the difference between the exercise price of the option and the closing stock price of our common stock on the last trading day of the period.
Time-Based Restricted Stock Units  
Schedule of stock-settled restricted stock unit activity

Weighted-

    

    

Average Grant

    

Aggregate

Units

Date Fair Value

Intrinsic

(In thousands except unit and per unit data)

Outstanding

Per Unit

Value (1)

Balance at December 31, 2024

728,426

$

14.33

$

12,478

Granted

473,075

$

13.83

Vested

(389,357)

$

14.72

Cancelled

(62,934)

$

14.39

Balance at September 30, 2025

749,210

$

13.80

$

10,369

(1)The aggregate intrinsic value of restricted stock units outstanding was based on our closing stock price on the last trading day of the period.
Performance-based stock-settled restricted stock units  
Schedule of stock-settled restricted stock unit activity

Weighted-

    

    

Average Grant

    

Aggregate

PSUs

Date Fair Value

Intrinsic

(In thousands except unit and per unit data)

Outstanding

Per Unit

Value (1)

Balance at December 31, 2024

272,919

$

15.19

$

4,675

Granted

168,722

$

15.38

Vested

(120,436)

$

16.67

Cancelled

(10,909)

$

13.85

Balance at September 30, 2025

310,296

$

14.76

$

4,294

(1)The aggregate intrinsic value of PSUs outstanding was based on our closing stock price on the last trading day of the period.